Skip to main content
Clinical Trials/NCT04653506
NCT04653506
Completed
N/A

Non - Opioid Treatments (Single Administration) for Pain During the Early Postpartum Period After Vaginal Delivery

Tel-Aviv Sourasky Medical Center1 site in 1 country107 target enrollmentNovember 28, 2020

Overview

Phase
N/A
Intervention
Paracetamol 1000 mg
Conditions
Pain
Sponsor
Tel-Aviv Sourasky Medical Center
Enrollment
107
Locations
1
Primary Endpoint
Pain relief after treatment with Paracetamol or Ibuprofen
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The investigators will examine the effectiveness of non-opioid analgesia (Paracetamol versus Ibuprofen) in the early postpartum period

Detailed Description

Postpartum pain is a common problem that leads to difficulties in basic daily activities, overuse of opioid medications, and even impaired breastfeeding ability. Non-opioid analgesia may play an essential role in reducing pain and improving the postpartum period including the ability to breastfeed and caring for the newborn. This study will compare non-opioid treatment - 1000 mg Paracetamol versus 400 mg Ibuprofen in order to determine the optimal pain relief treatment in the early postpartum period that may decrease the use of opioid analgesia. The investigators will evaluate the pain by the Numerical Rating Scale (NRS) index in the early postpartum period. The evaluation will conduct at 4-time points - while the women taking the pain relief (time 0), an hour later (time 1), 4, and 6 hours later (time 4 and time 6). The investigators will compare the analgetic effect of each drug and evaluate the need for additional analgesia whether opioid or not. Furthermore, the investigators will examine when women sought pain relief and whether pain relief contributes to the ability of Breastfeeding.

Registry
clinicaltrials.gov
Start Date
November 28, 2020
End Date
July 6, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Shmuel Kivity, MD

director head of clinical trails department, principal investigator, clinical professor

Tel-Aviv Sourasky Medical Center

Eligibility Criteria

Inclusion Criteria

  • Women between the ages of 18-50, who gave birth in a vaginal birth

Exclusion Criteria

  • Sensitivity to Paracetamol or Ibuprofen
  • After cesarean section
  • Received analgesia prior to study recruitment
  • Perineal tears grade 3 \\ 4
  • Women with chronic pain, rheumatic disease, fibromyalgia, or trauma
  • Women with a diagnosis or medication for anxiety or depression
  • Dropout for women whose newborns needed respiratory support with intubation, cooling, prolonged hospitalization in NICU exceeding one week

Arms & Interventions

Paracetamol group

Women who were treated with a double-blind mechanism in an envelope containing paracetamol pills (1000 mg)

Intervention: Paracetamol 1000 mg

Ibuprofen group

Women who were treated with a double-blind mechanism in an envelope containing Ibuprofen pills (400 mg)

Intervention: Ibuprofen 400 mg

Outcomes

Primary Outcomes

Pain relief after treatment with Paracetamol or Ibuprofen

Time Frame: 6 hours after intervention

After getting a pain relief treatment, the participants will answer a questionnaire about pain relief at 4 - time points: the time of getting the pain relief treatment (time 0), after an hour (time 1), 4 hours (time 4), and six hours (time 6). The pain rating will be on the Numeric Rating Scale (NRS) that labeled from zero (no pain) to ten ((worst pain).

Secondary Outcomes

  • Maximum pain location(6 hours after intervention)

Study Sites (1)

Loading locations...

Similar Trials